The mortality of myxcedema coma remains high. A contributory factor to this may be respiratory failure, which in this patient was successfully treated by intermittent positive pressure respiration (lPPR).
The patient was a 63-year-old woman, admitted to the Wessex Regional Neurosurgical Unit with deepening coma following a minor fall. Before the injury she had been getting increasingly tired and slow. Examination showed a semicomatose, obese woman with the classical appearance of myxcedema. Temperature 94°F, pulse 44/min, blood pressure 120/80. The chest showed no focal signs. Neurological examination was normal apart from delayed relaxation of ankle jerks, and a clinical diagnosis of myxcedema was made.
Subsequent investigations confirmed the diagnosis of primary myxcedema: Protein bound iodine 1-3 Ig/100 ml, serum cholesterol 420 mg/ 100 ml; 131I neck uptake at 24 hours 1-1%0, and following TSH 3-0%o. Electrocardiogram showed sinus bradycardia with low voltage complexes and flattened T waves.
The patient was slowly warmed and treated with triiodothyronine 20 tug six-hourly, hydrocortisone 75 mg six-hourly and procaine penicillin 600,000 units twelve-hourly. There was initial improvement with a rise in temperature and pulse rate and lessening of coma. Two days later respirations became shallow and irregular; she was not cyanosed and examination of the chest showed no focal signs. Chest X-ray showed equivocal linear atelectasis left lower zone. Arterial blood analysis showed a respiratory acidosis (Table 1, sample 1) . The patient deteriorated despite oxygen by facial mask (sample 2). She was therefore intubated and ventilated by IPPR, with rapid improvement (sample 3), and after forty-eight hours spontaneous respiration was re-established. Four days later she again relapsed (sample 4) and required further intubation and IPPR, again with rapid improvement (sample 5). Artificial ventilation was discontinued after forty-eight hours. The patient thereafter made an uneventful recovery and was discharged fit on replacement thyroxine therapy.
Comment
The mortality in reported series of myxcedema coma varies from 70 O to 80O% (Angel & Sash 1960 , Nielsen & Ranl0v 1964 , despite specific treatment with triiodothyronine and steroid therapy. Tn many reported cases the patient makes an initial favourable response to treatment, but then relapses and dies. Cardiac arrhythmias and hypotension may be responsible, but frequently the cause of death cannot be found. Respiratory acidosis has been described (Nordqvist et al. 1960 , Nielsen & Ranl0v 1964 , Buchanan et al. 1967 ), but the signs of this may not be conspicuous. Improvement occurs with artificial ventilation. Respiratory failure should therefore be looked for and treated energetically.
